
Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB:ZLDAF) is acquiring Health House International Limited (ASX: HHI), Benzinga has learned exclusively.
The acquisition will allow Zelira, a global leader in the research and development of cannabinoid medicines, to strengthen its distribution capabilities across Europe.